Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15328838 | 0.89 | TSHR (0.43) | TSHRL3MBTL1ALDH1A1TYRTACR1 | |
| SCHEMBL9968851 | 0.87 | ALDH1A1 (0.41) | TSHRL3MBTL1ALDH1A1TYRTACR1 | |
| SCHEMBL15341257 | 0.87 | TYR (0.40) | TSHRL3MBTL1ALDH1A1TYRTACR1 | |
| SCHEMBL9937665 | 0.85 | TSHR (0.41) | TSHRL3MBTL1ALDH1A1MEN1KMT2A | |
| SCHEMBL9937177 | 0.84 | L3MBTL1 (0.40) | TSHRL3MBTL1ALDH1A1TYRTACR1 | |
| SCHEMBL9969790 | 0.84 | ALDH1A1 (0.42) | TSHRL3MBTL1ALDH1A1TYRTACR1 | |
| SCHEMBL29392707 | 0.83 | PPARG (0.45) | TSHRL3MBTL1MEN1USP2KMT2A | |
| SCHEMBL9968844 | 0.83 | PPARG (0.45) | TSHRL3MBTL1MEN1USP2KMT2A | |
| SCHEMBL9937438 | 0.83 | ALDH1A1 (0.39) | TSHRL3MBTL1ALDH1A1TYRTACR1 | |
| SCHEMBL9938330 | 0.83 | MAPK1 (0.55) | TSHRL3MBTL1ALDH1A1POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2651886-B1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | ORÉAL L (FR) | 2015-03-04 | — | — | EP | claimed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | claimed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | claimed |
| EP-2651886-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'Oréal (FR) | 2013-10-23 | — | — | EP | claimed |
| WO-2012079938-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2012-06-21 | — | — | WO | claimed |
| EP-3393603-B1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INGREDIENTS | OREAL (FR) | 2023-01-18 | — | — | EP | disclosed |
| US-11260000-B2 | Composition in the form of nano or micro emulsion or with lamellar structure | L'OREAL (FR) | 2022-03-01 | — | — | US | disclosed |
| US-11154473-B2 | Composition comprising resorcinol or derivative thereof | L'OREAL (FR) | 2021-10-26 | — | — | US | disclosed |
| US-20190336421-A1 | COMPOSITION COMPRISING RESORCINOL OR DERIVATIVE THEREOF | L'OREAL (FR) | 2019-11-07 | — | — | US | disclosed |
| US-20180360705-A1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS | L'OREAL (FR) | 2018-12-20 | — | — | US | disclosed |
| US-20170087064-A1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | L'OREAL (FR) | 2017-03-30 | — | — | US | disclosed |
| EP-2651886-B1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | ORÉAL L (FR) | 2015-03-04 | — | — | EP | disclosed |
| EP-2651886-B1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | ORÉAL L (FR) | 2015-03-04 | — | — | EP | disclosed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | disclosed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | disclosed |
| US-8937187-B2 | Method for depigmenting keratin materials using resorcinol derivatives | L'OREAL (FR) | 2015-01-20 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2013-10-24 | — | — | US | disclosed |
| WO-2012079938-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | L'OREAL (FR) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180360705-A1 | TOPICAL DELIVERY SYSTEM FOR ACTIVE INREDIENTS | KRT18, CUTA, DSG1 | TSHR 3065/4885L3MBTL1 4421/4885ALDH1A1 1819/4885 |
| US-11154473-B2 | Composition comprising resorcinol or derivative thereof | NQO1, LRAT, RBP4 | TSHR 3913/4885L3MBTL1 3046/4885ALDH1A1 160/4885 |
| US-20190336421-A1 | COMPOSITION COMPRISING RESORCINOL OR DERIVATIVE THEREOF | NQO1, LRAT, RBP4 | TSHR 3913/4885L3MBTL1 3046/4885ALDH1A1 160/4885 |
| US-20130281507-A1 | METHOD FOR DEPIGMENTING KERATIN MATERIALS USING RESORCINOL DERIVATIVES | KRT18, KLHL20, IK | TSHR 4359/4885L3MBTL1 4589/4885ALDH1A1 222/4885 |
| US-20170087064-A1 | COMPOSITION IN THE FORM OF NANO OR MICRO EMULSION OR WITH LAMELLAR STRUCTURE | LRAT, LIPA, DAGLA | TSHR 3718/4885L3MBTL1 3662/4885ALDH1A1 1908/4885 |
| US-11260000-B2 | Composition in the form of nano or micro emulsion or with lamellar structure | LRAT, LIPA, DAGLA | TSHR 3718/4885L3MBTL1 3662/4885ALDH1A1 1908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.